Investment Thesis
BioGeneration Ventures specializes in seed-stage investments for innovative early-stage life sciences companies. Leveraging deep industry experience from pharma and biotech, the firm accelerates product development and shapes portfolio companies into attractive investment opportunities by providing hands-on operational and management expertise.
Stage Focus
Seed
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
Seed-stage biotech and life sciences companies developing disruptive solutions for high unmet medical needs
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
N/A
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
Investment Team (40)
A
Alexander Vos
Venture Partner
A
Andree Blaukat
Senior Advisor
A
Arnon Kater
Senior Advisor
A
Arnoud Dijkstra
Venture Partner
A
Arnoud Dijkstra, PhD
Venture Partner
C
Cyril Lesser
Vice President Finance | Funds
D
Daniela Couto
General Partner
D
Daniela Couto, PhD
General Partner
D
Diede Brunen
Principal
D
Diede Brunen, PhD
Principal
E
Edward van Wezel
Managing Partner and co-founder
E
Elena Ritsou
Venture Partner
E
Elena Ritsou , PhD
Venture Partner
E
Elena Ritsou, PhD
Venture Partner
E
Elisa Camorani
Senior Associate ESG and Impact
E
Elisa Camorani, MSc
Senior Associate ESG and Impact
E
Emile Voest
Senior Advisor
J
Jason Witherington
Venture Partner
J
Jennifer Fritzsche
Vice President Finance
J
Joern-Peter Halle, PhD
Venture Partner
J
John J.P. Kastelein
Senior Advisor
J
John J.P. Kastelein, MD PhD FESC
Senior Advisor
K
Keno Gutierrez
General Partner
K
Keno Gutierrez, PhD
Partner
L
Lars Erwig
Senior Advisor
L
Lars Erwig, MD, PhD
Senior Advisor
M
Machteld Groeneveld
Chief Compliance Officer & Legal Affairs
M
Maureen Wouters
Paralegal
O
Olga Ziessen
Investment Professional
O
Oskar Slotboom
Managing Partner
P
Patricia Vonk
AML/KYC Manager
R
Rachelle Young
Investor Relations Director
R
Rianne Ellenbroek
Principal
R
Rianne Ellenbroek is
Principal
R
Rianne Ellenbroek, PhD
Principal
R
Rob de Ree
Venture Partner
R
Robbert van de Griendt
Head of Investment Relations
R
Roger Ulrich
Senior Advisor
S
Silva Dezelan
Head of Impact and ESG
W
Wouter Verhoeven
Venture Partner
